Literature DB >> 16156866

The V617F mutation in Jak2 is not found in childhood acute lymphoblastic leukaemia.

Sarina Sulong, Marian Case, Lynne Minto, Bridget Wilkins, Andy Hall, Julie Irving.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16156866     DOI： 10.1111/j.1365-2141.2005.05697.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  9 in total

1.  Incidence and significance of the JAK2 V617F mutation in patients with chronic myeloproliferative disorders.

Authors:  S E Langabeer; F Ni Ainle; E Conneally; M Lawler
Journal:  Ir J Med Sci       Date:  2007-04-18       Impact factor: 1.568

Review 2.  Classification and diagnosis of myeloproliferative neoplasms according to the 2008 World Health Organization criteria.

Authors:  Martha Wadleigh; Ayalew Tefferi
Journal:  Int J Hematol       Date:  2010-02-27       Impact factor: 2.490

3.  Refractory anemia with ringed sideroblasts associated with marked thrombocytosis (RARS-T), another myeloproliferative condition characterized by JAK2 V617F mutation.

Authors:  Hadrian Szpurka; Ramon Tiu; Gurunathan Murugesan; Samer Aboudola; Eric D Hsi; Karl S Theil; Mikkael A Sekeres; Jaroslaw P Maciejewski
Journal:  Blood       Date:  2006-06-01       Impact factor: 22.113

Review 4.  Molecular pathways: molecular basis for sensitivity and resistance to JAK kinase inhibitors.

Authors:  Sara C Meyer; Ross L Levine
Journal:  Clin Cancer Res       Date:  2014-02-28       Impact factor: 12.531

5.  The implication of identifying JAK2 ( V617F ) in myeloproliferative neoplasms and myelodysplastic syndromes with bone marrow fibrosis.

Authors:  Randall J Olsen; Cherie H Dunphy; Dennis P O'Malley; Lawrence Rice; April A Ewton; Chung-Che Chang
Journal:  J Hematop       Date:  2008-08-28       Impact factor: 0.196

6.  Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray.

Authors:  Norihiko Kawamata; Seishi Ogawa; Martin Zimmermann; Motohiro Kato; Masashi Sanada; Kari Hemminki; Go Yamatomo; Yasuhito Nannya; Rolf Koehler; Thomas Flohr; Carl W Miller; Jochen Harbott; Wolf-Dieter Ludwig; Martin Stanulla; Martin Schrappe; Claus R Bartram; H Phillip Koeffler
Journal:  Blood       Date:  2007-09-21       Impact factor: 22.113

7.  Role of the erythropoietin receptor in ETV6/RUNX1-positive acute lymphoblastic leukemia.

Authors:  Andrea Inthal; Gerd Krapf; Dominik Beck; Ruth Joas; Max O Kauer; Lukas Orel; Gerhard Fuka; Georg Mann; E Renate Panzer-Grümayer
Journal:  Clin Cancer Res       Date:  2008-11-15       Impact factor: 12.531

8.  A Novel Homozygous Nucleotide Deletion in the JAK2 Gene in a Pediatric Patient with B-cell Precursor Acute Lymphoblastic Leukemia.

Authors:  Dilara Fatma Akın; Emel Akkaya; A Emin Kürekçi; Ciğdem Arslan; Ustün Ezer; Nejat Akar
Journal:  Turk J Haematol       Date:  2012-06-15       Impact factor: 1.831

Review 9.  Molecular drug targets in myeloproliferative neoplasms: mutant ABL1, JAK2, MPL, KIT, PDGFRA, PDGFRB and FGFR1.

Authors:  Ayalew Tefferi
Journal:  J Cell Mol Med       Date:  2008-10-23       Impact factor: 5.310
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.